• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Future of the particle replication in nonwetting templates (PRINT) technology.无湿模板颗粒复制(PRINT)技术的未来。
Angew Chem Int Ed Engl. 2013 Jun 24;52(26):6580-9. doi: 10.1002/anie.201209145. Epub 2013 May 13.
2
The pursuit of a scalable nanofabrication platform for use in material and life science applications.寻求一种可扩展的纳米制造平台,用于材料和生命科学应用。
Acc Chem Res. 2008 Dec;41(12):1685-95. doi: 10.1021/ar8000348.
3
Co-opting Moore's law: Therapeutics, vaccines and interfacially active particles manufactured via PRINT®.借助摩尔定律:通过 PRINT® 制造的疗法、疫苗和具有界面活性的粒子。
J Control Release. 2016 Oct 28;240:541-543. doi: 10.1016/j.jconrel.2016.07.019. Epub 2016 Jul 14.
4
PRINT: a novel platform toward shape and size specific nanoparticle theranostics.打印:一种针对形状和大小特异的纳米颗粒治疗的新平台。
Acc Chem Res. 2011 Oct 18;44(10):990-8. doi: 10.1021/ar2000315. Epub 2011 Aug 2.
5
Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials.单分散、特定形状纳米生物材料的直接制造与获取
J Am Chem Soc. 2005 Jul 20;127(28):10096-100. doi: 10.1021/ja051977c.
6
Shape-specific, monodisperse nano-molding of protein particles.蛋白质颗粒的形状特异性单分散纳米成型
J Am Chem Soc. 2008 Apr 23;130(16):5438-9. doi: 10.1021/ja8014428. Epub 2008 Apr 1.
7
Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles.可扩展、形状特定的自上而下的制造方法,用于合成工程胶体粒子。
Langmuir. 2010 Aug 17;26(16):13086-96. doi: 10.1021/la903890h.
8
Engineering nanomedicines using stimuli-responsive biomaterials.利用刺激响应型生物材料工程纳米药物。
Adv Drug Deliv Rev. 2012 Aug;64(11):1021-30. doi: 10.1016/j.addr.2012.01.003. Epub 2012 Jan 14.
9
Challenging nature's monopoly on the creation of well-defined nanoparticles.挑战自然界对形态明确的纳米颗粒的垄断。
Nanomedicine (Lond). 2010 Jun;5(4):633-9. doi: 10.2217/nnm.10.34.
10
Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.用于工程药物治疗的纳米制造颗粒:PRINT纳米颗粒的初步生物分布研究
J Control Release. 2007 Aug 16;121(1-2):10-8. doi: 10.1016/j.jconrel.2007.05.027. Epub 2007 Jun 2.

引用本文的文献

1
Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside.癌症治疗中的纳米医学:从实验室到临床的当前视角
Mol Cancer. 2025 Jun 9;24(1):169. doi: 10.1186/s12943-025-02368-w.
2
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape.临床视角下的纳米颗粒疗法:分类、上市产品及监管格局
Small. 2025 Jun 2:e2502315. doi: 10.1002/smll.202502315.
3
Antibody-Nanoparticle Conjugates in Therapy: Combining the Best of Two Worlds.抗体-纳米颗粒偶联物在治疗中的应用:融合两种优势。
Small. 2025 Apr;21(15):e2409635. doi: 10.1002/smll.202409635. Epub 2025 Mar 6.
4
Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review.基于载体的干粉吸入器性能优化:综述
Pharmaceutics. 2025 Jan 13;17(1):96. doi: 10.3390/pharmaceutics17010096.
5
Production of Hydrophobic Microparticles at Safe-To-Inject Sizes for Intravascular Administration.生产用于血管内给药的安全可注射尺寸的疏水性微粒。
Pharmaceutics. 2025 Jan 6;17(1):64. doi: 10.3390/pharmaceutics17010064.
6
Challenges and opportunities of poly(amino acid) nanomedicines in cancer therapy.聚(氨基酸)纳米药物在癌症治疗中的挑战与机遇。
Nanomedicine (Lond). 2024;19(29):2495-2504. doi: 10.1080/17435889.2024.2402677. Epub 2024 Oct 9.
7
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy.工程化癌症纳米疫苗:癌症治疗的新前沿
Nanomicro Lett. 2024 Sep 30;17(1):30. doi: 10.1007/s40820-024-01533-y.
8
Air-through-precursor suction-augmented replica molding for fabrication of anisotropic microparticles in gas-impermeable molds.用于在不透气模具中制造各向异性微粒的通气前驱体抽吸增强复制成型法。
RSC Adv. 2024 Aug 12;14(35):25190-25197. doi: 10.1039/d4ra04719b.
9
Scalable lipid droplet microarray fabrication, validation, and screening.可扩展的脂滴微阵列的制作、验证和筛选。
PLoS One. 2024 Jul 5;19(7):e0304736. doi: 10.1371/journal.pone.0304736. eCollection 2024.
10
Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials.迈向用于癌症临床试验的聚合物纳米治疗剂的扩大生产。
Nano Today. 2024 Jun;56. doi: 10.1016/j.nantod.2024.102314. Epub 2024 May 18.

本文引用的文献

1
The Patterning of Sub-500 nm Inorganic Oxide Structures.亚 500nm 无机氧化物结构的图案化。
Adv Mater. 2008 Jul 17;20(14):2667-73. doi: 10.1002/adma.200702495. Epub 2008 Jun 2.
2
Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.载多西紫杉醇不同粒径和形状纳米粒在荷 SKOV-3 人卵巢癌移植瘤小鼠的体内药代动力学研究
Nanomedicine. 2013 Jul;9(5):686-93. doi: 10.1016/j.nano.2012.11.008. Epub 2012 Dec 6.
3
Development of a nanoparticle-based influenza vaccine using the PRINT technology.基于纳米颗粒的流感疫苗的研发采用 PRINT 技术。
Nanomedicine. 2013 May;9(4):523-31. doi: 10.1016/j.nano.2012.11.001. Epub 2012 Nov 22.
4
The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles.粒径对低模量水凝胶 PRINT 颗粒生物分布的影响。
J Control Release. 2012 Aug 20;162(1):37-44. doi: 10.1016/j.jconrel.2012.06.009. Epub 2012 Jun 15.
5
Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications.聚乙二醇-前药缀合物:概念、设计与应用
J Drug Deliv. 2012;2012:103973. doi: 10.1155/2012/103973. Epub 2012 May 7.
6
Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores.形状比和变形性对纳米粒子通过纳米孔渗出的影响。
Langmuir. 2012 Jun 12;28(23):8773-81. doi: 10.1021/la301279v. Epub 2012 May 29.
7
Rendering protein-based particles transiently insoluble for therapeutic applications.使基于蛋白质的颗粒暂时不可溶,用于治疗应用。
J Am Chem Soc. 2012 May 30;134(21):8774-7. doi: 10.1021/ja302363r. Epub 2012 May 17.
8
Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.从 PRINT 纳米粒中掺入和控制硅醚前药的释放。
J Am Chem Soc. 2012 May 9;134(18):7978-82. doi: 10.1021/ja301710z. Epub 2012 Apr 30.
9
Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.用于呼吸道药物递送及其他制药应用的微加工工程颗粒系统。
J Drug Deliv. 2012;2012:941243. doi: 10.1155/2012/941243. Epub 2012 Feb 9.
10
Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing.还原响应性 siRNA 缀合水凝胶纳米颗粒用于基因沉默。
J Am Chem Soc. 2012 May 2;134(17):7423-30. doi: 10.1021/ja300174v. Epub 2012 Apr 19.

无湿模板颗粒复制(PRINT)技术的未来。

Future of the particle replication in nonwetting templates (PRINT) technology.

机构信息

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Angew Chem Int Ed Engl. 2013 Jun 24;52(26):6580-9. doi: 10.1002/anie.201209145. Epub 2013 May 13.

DOI:10.1002/anie.201209145
PMID:23670869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4157646/
Abstract

Particle replication in nonwetting templates (PRINT) is a continuous, roll-to-roll, high-resolution molding technology which allows the design and synthesis of precisely defined micro- and nanoparticles. This technology adapts the lithographic techniques from the microelectronics industry and marries these with the roll-to-roll processes from the photographic film industry to enable researchers to have unprecedented control over particle size, shape, chemical composition, cargo, modulus, and surface properties. In addition, PRINT is a GMP-compliant (GMP=good manufacturing practice) platform amenable for particle fabrication on a large scale. Herein, we describe some of our most recent work involving the PRINT technology for application in the biomedical and material sciences.

摘要

无液模板中的粒子复制(PRINT)是一种连续的、卷对卷的、高分辨率的成型技术,可用于设计和合成精确定义的微纳米粒子。该技术采用微电子工业中的光刻技术,并将其与照相胶片工业中的卷对卷工艺相结合,使研究人员能够对粒子的大小、形状、化学组成、有效载荷、模量和表面性能进行前所未有的控制。此外,PRINT 是一种符合 GMP(良好生产规范)的平台,适用于大规模的粒子制造。本文介绍了我们最近在生物医学和材料科学领域应用 PRINT 技术的一些工作。